checkAd

    SHAREHOLDER ALERT  1113  0 Kommentare LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against IRadimed Corporation and Its Board of Directors and a Lead Plaintiff Deadline of November 10, 2014 -- IRMD

    NEW YORK, NY--(Marketwired - Sep 22, 2014) - Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Florida on behalf of investors who purchased IRadimed Corporation ("IRadimed" or the "Company") (NASDAQ: IRMD) securities between July 15, 2014 and September 2, 2014.

    For more information, click here: http://zlk.9nl.com/iradimed-irmd.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Apple Inc.!
    Long
    159,02€
    Basispreis
    1,00
    Ask
    × 14,27
    Hebel
    Short
    178,26€
    Basispreis
    0,87
    Ask
    × 14,25
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    The complaint alleges that throughout the Class Period IRadimed failed to disclose that: (a) the Company's infusion pump systems had been significantly modified, a fact that could significantly affect the safety and/or effectiveness of the devices; (b) as a result of said modifications, the Company's products are "adulterated" and "misbranded" under applicable federal regulations; (c) the Company's mRidium 3860+ infusion pump requires separate FDA clearance from its mRidium 3860 and mRidium 3850.

    On September 3, 2014, IRadimed announced it had received a warning letter from the FDA requesting the Company cease all activities that misbrand or adulterate its mRidium 3860, mRidium 3850, and mRidium 3860+ infusion pumps.

    If you suffered a loss in IRadimed you have until November 10, 2014 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/iradimed-irmd

    Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

    CONTACT:
    Levi & Korsinsky, LLP
    Joseph Levi, Esq.
    Eduard Korsinsky, Esq.
    30 Broad Street - 24th Floor
    New York, NY 10004
    Tel: (212) 363-7500
    Toll Free: (877) 363-5972
    Fax: (866) 367-6510
    www.zlk.com



    Diskutieren Sie über die enthaltenen Werte



    Verfasst von Marketwired
    SHAREHOLDER ALERT LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against IRadimed Corporation and Its Board of Directors and a Lead Plaintiff Deadline of November 10, 2014 -- IRMD NEW YORK, NY--(Marketwired - Sep 22, 2014) - Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Florida on behalf of investors who purchased IRadimed Corporation …

    Schreibe Deinen Kommentar

    Disclaimer